Prevalence and Course of
Thrombocytopenia in Culture Positive and Culture Negative Neonatal
Sepsis
Rabindran1, Hemant
Parakh2, Ramesh J K3, Prashant Reddy4
1Dr. Rabindran, Junior Consultant Neonatologist, 2Dr.Hemant Parakh,
Consultant Neonatologist, 3Dr.Ramesh J K, Consultant Pediatrician, 4Dr.Prashant Reddy, Consultant Pediatrician, Sunrise Superspeciality
Children’s Hospital, Hyderabad, Andhra Pradesh, India
Address for
Correspondence: Dr Rabindran, E mail:
rabindranindia@yahoo.co.in ; rabindranchandran@gmail.com
Abstract
Introduction: Neonatal Sepsis is commonly associated with
thrombocytopenia. Objective: To assess the prevalence and course of
thrombocytopenia in culture positive and culture negative neonatal
sepsis in comparison to normal newborns. Methods: This is a
retrospective case analysis of 533 neonates between January-2012 to
December-2014. The parameters examined were Baseline Platelet Count,
Change In Platelet Count, (Baseline Platelet Count- Change In Platelet
Count)/ Baseline Platelet Count, Platelet Nadir, Incidence, Duration
& Severity of Thrombocytopenia. Statistical Analysis: All data
were collected in validated preformatted proforma sheet &
analysed using appropriate statistical methods. Results: Among 533
neonates, 21.2% had Culture negative sepsis, 9.75% had culture positive
sepsis & 69.04% had no sepsis. The prevalence of early onset
sepsis was 17.44% & late onset sepsis was 13.50%. About 24.76%
babies had thrombocytopenia; 9.56% had mild thrombocytopenia, 10.13%
had moderate & 5.06% had severe thrombocytopenia. Late onset
sepsis was associated with significant thrombocytopenia. Culture
positive sepsis had significant drop in platelets with lower platelet
nadir, higher incidence, more severe & prolonged
thrombocytopenia compared to culture negative sepsis & normal
neonates. Conclusion:
There are quantitative differences in the platelet response to neonatal
sepsis, particularly to culture positive sepsis. Hematological changes
in platelet count induced by culture proven and culture negative
neonatal sepsis can be used to make an early diagnosis and prompt
management of neonatal sepsis.
Key words:
Thrombocytopenia, Culture Positive Sepsis, Culture Negative Sepsis
Manuscript received:
5th Dec 2014, Reviewed:
16th Dec 2014
Author Corrected:
29th Jan 2014, Accepted
for Publication: 11th Feb 2015
Introduction
Neonatal Sepsis is a clinical syndrome characterised by signs and
symptoms of infection with or without accompanying bacteremia in the
first month of life [1]. It is extremely important to make an early
diagnosis of neonatal sepsis for the prompt institution of
anti-microbial therapy, which improves the outcomes [2]. CRP &
Platelet count are diagnostic markers of neonatal sepsis [3,4].
We have conduacted this study to assess the prevalence and course
of
thrombocytopenia in culture positive and culture negative neonatal
sepsis in comparison to normal newborns.
Methodology
This is a retrospective case analysis between January-2012 to
December-2014 in a single centre. Blood samples of all the patients
included in this study were obtained for CBC and CRP levels. Blood
culture was done when indicated. Name, date of admission, age, platelet
count, CRP levels, blood culture reports were recorded on a data
form.We enrolled 533 eligible neonates. The data was analysed for
differences in platelet count in terms of Culture positive, Culture
negative sepsis & no sepsis. All patients included in this
study received appropriate antibiotics. Unit Protocol for Investigation
of Neonatal Sepsis: Soon after admission two ml blood sample was taken
in EDTA vacutainer and was processed for Platelet count. Another 2 ml
blood sample was taken for conventional blood culture. Also 1 ml blood
sample was taken for estimation of a qualitative CRP result. Direct
counting of platelets in an improved Neubauer`s Chamber was done.
Platelet count less than 1.5 Lakh / cumm was considered abnormal. CRP
in serum was estimated by CRP Turbi Latex Kit using Latex turbimetry.
Test showed positivity when CRP value was more than 6 mg/ L. Blood was
collected for blood culture in BD BACTEC bottles & cultured in
Sabouraud’s Dextrose agar & Brain Heart Infusion
Broth and colony growth was observed. Smears were made from peripheral
blood and stained by Leishmans stain and examined to confirm
thrombocytopenia. The platelet count & CRP used for this study
was the one obtained at the same time as the positive blood culture or
the one closest to the time the blood culture was drawn in cases of
neonatal sepsis and the admission values in those babies with no sepsis.
Interventions:
Management of neonatal sepsis as per standard unit protocol. The study
was approved by the Hospital Research and Ethics Committee.
Definition of Parameters:
The parameters that were examined in this study were
Baseline Platelet Count:
Platelet count obtained at least 24 hours before the time that the
blood culture was obtained in cases of neonatal sepsis or the admission
values in those babies with no sepsis.
Change In Platelet Count:
Platelet count at the time of onset of sepsis in cases of neonatal
sepsis or the second CBC values in those babies with no sepsis.
Platelet Nadir:
Lowest platelet count obtained during a 20-day period starting from the
time the initial blood culture was drawn in cases of neonatal sepsis or
during a 20-day period since admission in those babies with no sepsis.
Incidence of
Thrombocytopenia: Number of episodes with a platelet nadir
of less than 1,50,000/mm3 during a 20-day period starting from the time
the initial blood culture was drawn in cases of neonatal sepsis or
during a 20-day period since admission in those babies with no sepsis.
Duration of
Thrombocytopenia: Number of continuous days that the
platelet count remained less than 1,50,000/mm 3. If the neonate had no
Thrombocytopenia at the time of sepsis, the duration was considered to
be zero.
Severity of
Thrombocytopenia: [5]
No Thrombocytopenia
- Platelet count more than 1,50, 000/mm3
Mild Thrombocytopenia
- Platelet count between
1,00,000 to1,50,000/mm3
Moderate Thrombocytopenia - Platelet
count between 50,000 to 1,00,000/mm3
Severe Thrombocytopenia
- Platelet count less than
50,000/mm3
Culture Negative Sepsis: was defined as those with clinical signs and
symptoms of sepsis, without growth of any pathogen from blood, but with
presence of CRP > 6mg/L [6].
Statistical Analysis
All the data were collected in validated preformatted proforma sheet
and analysed using software Statistical Package for Social Sciences.
Categorical variables were analyzed using Chi-square analysis with
Yates correction. Student‘t’ test was used to
compare the means. A p-value of < 0.05 was considered
significant. Analysis of variance was used to compare groups, and data
are expressed as mean ± standard deviation. Scheffe test was
used for pairwise comparisons.
Results
533 babies were studied. About 113 babies (21.2%) had Culture negative
sepsis, 52 babies (9.75%) had culture positive sepsis & 368
babies (69.04%) had no sepsis. The prevalence of sepsis in our study
was 30.95%. The prevalence of early onset sepsis was 17.44% &
late onset sepsis was 13.50%. 72 babies (63.71%) had early onset sepsis
& 41 (36.28%) had late onset sepsis among culture negative
sepsisgroup. 21 babies (40.38%) had early onset sepsis & 31
(59.61%) had late onset sepsis among culture positive sepsis group,
(Chi square p <0.0001, significant). Totally 132 babies (24.76%)
had thrombocytopenia. 51 babies (9.56%) had mild thrombocytopenia, 54
babies (10.13%) had moderate & 27 babies (5.06%) had severe
thrombocytopenia. Analysing Prevalence of thrombocytopenia among the
groups, 48 babies (42.47%) among 113 babies with culture negative
sepsis had thrombocytopenia, 38 babies (73.07%) among 52 babies with
culture positive sepsis had thrombocytopenia, 46 babies (12.50%) among
368 babies with no sepsis had thrombocytopenia, (Chi square p
<0.0001, significant). Prevalence of thrombocytopenia was more
in culture positive sepsis. Analysing Prevalence of thrombocytopenia
among the type of sepsis, 45 babies (48.38%) among 93 babies with early
sepsis had thrombocytopenia, 41 babies (56.94%) among 72 babies with
late onset sepsis had thrombocytopenia, 46 babies (12.5%) among 368
babies with no sepsis had thrombocytopenia, (Chi square p
<0.0001 , significant). Prevalence of thrombocytopenia was more
in late onset sepsis.
Table 1: Platelet
Variations among no sepsis, culture negative & culture positive
sepsis
Analysis of variance was used to compare the groups, and data was
expressed as mean ± standard deviation. There was a
significant fall in platelet counts when compared with baseline values
in culture positive patients. Results were statistically significant
when compared with culture negative and normal neonates. Similar
findings were noticed for platelet nadir. Culture positive sepsis had
higher incidence & more prolonged thrombocytopenia along with
more severity when compared to culture negative sepsis and normal
neonates.
Table 2: Platelet
variations among no sepsis, early onset & late onset sepsis
There was a significant fall in platelet counts when compared with
baseline values in babies with late onset sepsis. Results were
statistically significant when compared with early onset sepsis.
Similar findings were noticed for platelet nadir. Late onset sepsis had
higher incidence & more prolonged thrombocytopenia along with
more severity when compared to early onset sepsis.
Discussion
Prevalence of Sepsis:
In our study, 21.2% babies had Culture negative sepsis & 9.75%
had culture positive sepsis. The overall prevalence of sepsis in our
study was 30.95%. Prevalence between 20-30% was noted in studies by
Khalessi N et al. [7], Roberts I et al.[8], Beiner ME et al.[9], Bolat
F et al.[10]. However lower prevalence of 16% was noted by Jack D.Guida
et al.[11]. The prevalence of early onset sepsis in our study was
17.44%. The prevalence of early onset sepsis was between 20-30% in
studies by Khalessi N et al.[7], Roberts I et al.[8], Beiner ME et
al.[9], Bolat F et al.[10]. The prevalence of late onset sepsis in our
study was 13.50%. However Bizzarro MJ et al.,[12] & Van den
Hoogen etal.[13] observed that late-onset sepsis was more common in
their studies.
Prevalence of Culture
Positivity: The culture positivity in our study was
31.51%. Wide variations in culture positivity have been noted in
various studies. It was between 20-30% in studies by Sharma et al.[14],
Ramesh Bhat Y et al.[15], Ahmed et al.[16], Baltimore et al [17],
Gladstone et al [18], d Haens et al.[19], Qazi Iqbala b et al.[20]
& Kayange N et al.[21]. About 34.45% babies had culture
positivity in a study by Anil K Gupta et al.[22]. It was between 40-50%
in other studies[23-25]. Deepa et al.[26] & Buch et al.[27]
noted culture positivity in 54.17%.The culture positivity was between
60-70% in studies by Tallur et al.[28], Muhammad Ali Sheikh et al.[29],
Mishra UK et al.[30] & Kohli-Kochhar R et al.[31].
Prevalence of
Thrombocytopenia: Totally 24.76% of our babies had
thrombocytopenia in this study. The prevalence of thrombocytopenia
among hospitalized neonates was between 22 - 35% in other
studies[32-39]. It was between 15-20% in studies by Khalessi N et
al.[7], Gupta et al.[40], Anil K Gupta et al.[22], Qazi Iqbala b et
al.[20]. However a higher prevalence of 69.9% was noted by Kyoung Hee
Choi et al.[41] & 53% by Zaccheaus A Jeremiah et al.[5].
Overall the prevalence of thrombocytopenia was 52.12% among babies with
sepsis. It was between 50-60 % in studies by Guida et al.[11],
Zaccheaus A Jeremiah et al.[5], Mannan et al.[42] ,Torkaman M et
al.[43] & Tiago de Oliveira Boechat et al.,[44].
Lower prevalence of 24.1% by Khalessi N
et al.[7] & 24.7% by Charoo BA et al.[45] were noted.
Prevalence of
Thrombocytopenia Among Culture Positive Sepsis: There was
a significant high prevalence of thrombocytopenia (73.07%) among babies
with culture positive sepsis. Results were statistically significant
when compared with culture negative and normal neonates (Chi square p
<0.0001, significant). Guida JD et al [11] & Mannan MA
et al.[42] noted that the prevalence was 50% among babies with culture
positive sepsis.
Prevalence of
Thrombocytopenia among Early & Late Onset Sepsis:
Significantly higher prevalence of thrombocytopenia (56.94%) was noted
among late onset sepsis when compared with early onset sepsis (48.38%)
(Chi square p <0.0001, significant). Khalessi N et al.[7]
& Zaccheaus A Jeremiah1 et al.[5] noted the prevalence of
thrombocytopenia among early onset sepsis as 67.7% & 84.84%
respectively in their studies. Charro et al.[45] noted the prevalence
of thrombocytopenia among late onset sepsis as 59.5% which was
comparable to our study.
Platelet Variations among
No Sepsis, Culture Negative & Culture Positive Sepsis:
There was a significant fall in platelet counts when compared with
baseline values in culture positive patients. Results were
statistically significant when compared with culture negative and
normal neonates. Similar findings were noticed for platelet nadir.
Culture positive sepsis had higher incidence & more prolonged
thrombocytopenia along with more severity when compared to culture
negative sepsis and normal neonates. Deepa S et al.[26] also noted
lower platelet counts in culture positive sepsis as compared to normal
babies.
Platelet Variations among
No Sepsis, Early Onset & Late Onset Sepsis: We
noted a significant fall in platelet counts when compared with baseline
values in babies with late onset sepsis. Results were statistically
significant when compared with early onset sepsis. Similar findings
were noticed for platelet nadir. Late onset sepsis had higher incidence
& more prolonged thrombocytopenia along with more severity when
compared to early onset sepsis.
Severity of
Thrombocytopenia: In our study, 9.56% babies had mild
thrombocytopenia,10.13% had moderate & 5.06% had severe
thrombocytopenia. Zaccheaus A Jeremiah et al.[5] noted that 39.4% had
mild thrombocytopenia, 12.1% had moderate & 1.5% had severe
thrombocytopenia. Anil K Gupta et al. [22] noted that 8% had mild
thrombocytopenia, 4.5% had moderate & 4.2% had severe
thrombocytopenia. Severe thrombocytopenia was found to be present in
5.4%, 2.4%, 2.4% & 6% in studies by Khalessi N et al.[7],
Roberts I et al.[33] , Christensen et al.[46] & Murray NA et
al.[47] respectively. Sainio S et al.[48], De Moerloose P et al.[49],
Burrows RF et al.[50], Uhrynowska M, et al.[51] & Dreyfus M et
al.[52] observed that severe thrombocytopenia occurs in
0.1–0.5% of neonatal sepsis.
Summary: We
noted significant drop in platelet count among late onset sepsis
.Significant variations of all platelet indices were noted among lower
gestational age babies. Culture positive sepsis was associated with
significant drop in platelets with lower platelet nadir, higher
incidence, more severe & prolonged thrombocytopenia when
compared to culture negative sepsis & normal neonates.
Conclusion
There are quantitative differences in the platelet response to neonatal
sepsis, particularly to culture positive sepsis. Hematological changes
in platelet count induced by culture proven and culture negative
neonatal sepsis can be used to make an early diagnosis and prompt
management of neonatal sepsis.
Funding:
Nil, Conflict of
interest: Nil
Permission from IRB:
Yes
References
1. Shankar M J, Agarwal R and Deorari AK (2008). Sepsis in the new
born. Indian J Pediatr;75 (3) 261- 270.
2. Sucilathangam G. Early Diagnostic Markers for Neonatal Sepsis:
Comparing Procalcitonin and CReactive Protein. J Clin Diagn Res. 2012
May (Suppl-2), Vol-6(4): 627- 631.
3. Modanlou HD, Ortiz OB. Thrombocytopenia in neonatal infection. Clin
Pediatr (Phila). 1981;20:402–407.
4. Storm W. Use of thrombocytopenia for the early identification of
sepsis in critically ill newborns. Acta Paediatr, Acad Sci Hung.
1982(23):349–355.
5. Zaccheaus A Jeremiah, Justina E Oburu. Pattern and prevalence of
neonatal thrombocytopenia in Port Harcourt, Nigeria;Pathol Lab Med Int.
2010:(2) 27–31.
6. Marzban A1, Samaee H, Mosavinasab N. Changing trend of empirical
antibiotic regimen: experience of two studies at different periods in a
neonatal intensive care unit in Tehran, Iran. Acta Med Iran. 2010
Sep-Oct; 48(5):312-5.
7. Khalessi N , Khosravi N , Sanii S , Zareh Mehrjerdi F. The
Prevalence and Risk Factors for Neonatal Thrombocytopenia among
Newborns Admitted to Intensive Care Unit of Aliasghar
Children’s Hospital ; Ir J Blood And Cancer; Vol
5(2);2013.
8. Roberts I, Murray NA. Neonatal thrombocytopenia. Semin Fetal
Neonatal Med. 2008;13(4):256-64.
9. Beiner ME, Simchen MJ, Sivan E, Chetrit A, Kuint J, Schiff E. Risk
factors for neonatal thrombocytopenia in preterm infants. Am J
Perinatol. 2003;20(1):49-54. [PubMed]
10. Bolat F, Kılıç SÇ, Oflaz MB, Gülhan
E, Kaya A, Güven AS. The prevalence and outcomes of
thrombocytopenia in a neonatal intensive care unit: a three-year
report. Pediatr Hematol Oncol 09/2012; 29(8):710-20.
11. Jack D Guida, Anette M. Kunig, Kathleen H Leef, Steven E McKenzie,
David A. Paul. Platelet Count and Sepsis in Very Low Birth Weight
Neonates: Is There an Organism-Specific Response? Pediatrics
2003;(111):1411–1415.
12. Bizzarro MJ, Dembry LM, Baltimore RS. Changing patterns in neonatal
Escherichia coli sepsis and ampicillin resistance in the era of
intrapartum antibiotic prophylaxis. Pediatrics.
2008;(121):689–696.
13. Van den Hoogen A, Gerards LJ, Verboon-Maciolek MA. Long-term trends
in the epidemiology of neonatal sepsis and antibiotic susceptibility of
causative agents. Neonatology. 2010;(97):22–28.
14. Sharma A, Krishna Kutty CV, Sabharwal U, Sushila and Mohan H.
Evaluation of sepsis screen for diagnosis of neonatal septicemia.
Indian J Pediatr (1993);60(4);559-563. [PubMed]
15. Ramesh Bhat Y, Lincy P. Early Onset of Neonatal Sepsis: Analysis of
the Risk Factors and the Bacterial Isolates by Using the BacT Alert
System; J Clin Diagn Res. 2011-November(Suppl-2),Vol-5(7):1385-1388.
16. Ahmed NU, Chowdhury MA, Hoque M, Darmstadt GL. The clinical and
bacteriological profile of neonatal septicemia in a tertiary level
paediatric hospital in Bangladesh. Indian Paediatr 2002;(39):1034-
1039.
17. Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brein KL.
Early-onset of neonatal sepsis in the era of group B Streptococcal
prevention. Paediatrics 2001;(108):1094-98. [PubMed]
18. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS. A ten-year
review of neonatal sepsis and comparison with a previous fifty-year
experience. Paediatr Infect Dis J;1990;(9):819–25.
19. d’Haens EJ, Roell-Schorer EAM, van-Elzakker EPM,
de-Beaufort AJ, Sprij AJ. Clinical availability of neonatal blood
culture results at 48 hours. J Neonatol -Perinatal Med 2009;(2):109-13.
[PubMed]
20. Qazi Iqbalab, Charoo Bashira, Sheikh Mushtaqa, Asif Ahmada, Akhtar
Rasool Babaa. Thrombocytopenia and other hematological parameters in
culture positive neonatal sepsis and their impact; India J Pediatr
Infectious Dis 8 (2013) 25–29. [PubMed]
21. Kayange N, Kamugisha E, Mwizamholya DL, Jeremiah S and Mshana SE.
Predictors of positive blood culture and deaths among neonates with
suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania. BMC
Pediatr,;(10)39. [PubMed]
22. Anil K Gupta, Sudarshan Kumari, Abhishek Singhal, Aruna
Bahl.Neonatal thrombocytopenia and platelets transfusion; Asian J
Transfusion Sci, Vol.6(2),July-December(2012);161-164.
23. Hussein AB, Khaled MAR. CRP in neonate with suspected septicemia;
Rawal Medical J;(20070;32(1)24-27. [PubMed]
24. Lee YH, Kim SW, Kim MH and Choi YS. Predictive factors and its
usefulness in early diagnosis of neonatal sepsis. J Kor Social
Neonatol;(1997);4(2)195-204.
25. Karthikeyan G, Premkumar K. Neonatal sepsis: Staphylococcus aureus
as the predominant pathogen. Indian J Paediatr 2001;(68):715-717.
26. Deepa S, Manjunatha,Venkatesha D. Screening cord blood is a better
diagnosing method for early onset neonatal septicemia; Indian J Med Res
Pharma Sci,October 2014;1(5)ISSN:2349 – 5340.
27. A.C. Buch, V. Srivastava, Harsh Kumar, P.S.Jadhav. Evaluation of
haematological profile in early diagnosis of clinically suspected cases
of neonatal sepsis;Int J Basic App Med
Sci;ISSN:2277-2103;(2011);Vol.1(1) September-December.
28. Tallur SS, Kasturi AV, Nadgir SD, Krishna BVS. A
clinico-bacteriological study of neonatal septicaemia in Hubli. Indian
J Paediatr 2000;(67):169-74.
29. Sidra Younis, Muhammad Ali Sheikh, Amjad Ali Raza.Diagnostic
Accuracy of C-Reactive Protein in Neonatal Sepsis; J Bioresource
Management;Volume 1(1)Article 1
30. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the
diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal
Ed 2006, 91(3):F208-212.
31. Kohli-Kochhar R, Omuse G, Revathi G: A ten-year review of neonatal
bloodstream infections in a tertiary private hospital in Kenya. J
infect developing countries; (2011), 5(11). [PubMed]
32. Roberts I, Murray NA. Neonatal thrombocytopenia. Semin Fetal
Neonatal Med. 2008;13(4):256-64.
33. Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate.
Blood Rev. 2008;22(4):173-86. [PubMed]
34. Roberts IA, Murray NA. Neonatal thrombocytopenia: new insights into
pathogenesis and implications for clinical management. Curr Opin
Pediatr. 2001;13:16–21.
35. Castle V, Andrew M, Kelton J. Frequency and mechanism of neonatal
thrombocytopenia. J Pediatr (1986);108:749–55.
36. Mehta P, Rohitkumar V, Neumann L, et al. Thrombocytopenia in the
high risk infant. J Pediatr (1980);(97):791–4.
37. Abdalla Alshorman. The Effect of Neonatal Sepsis on Platelet Count
and their Indices et al. 83 J Med J 2008; June:Vol. 42. [PubMed]
38. Aman I, Hassan KA, Ahmad TM. The study of thrombocytopenia in sick
neonates. J Coll Physicians Surg Pak; 2004 May;14(5):282-5. [PubMed]
39. Murray NA, Roberts IAG. Circulating megakaryocytes and their
progenitors in early thrombocytopenia in preterm neonates. Pediatr Res
1996;(40):112–19.
40. Gupta AK, Kumari S, Singhal A, Bahl A. Neonatal thrombocytopenia
and platelets transfusion. Asian J Transfus Sci.
2012;6(2):161-4.
41. Kyoung Hee Choi , Sung Soo Rim , Byung Min Moon ,Ki Bok Kim. Study
on platelet counts and indices in neonates ; ;Korean J Pediatr (1996)
March;39(3) :338-345.
42. Mannan MA, Shahidullah M, Noor MK, Islam F, Alo D, Begum NA.
Utility of creactive protein and hematological parameters in the
detection of neonatal sepsis. Mymensingh Med J; 2010;(19):259-63. [PubMed]
43. Torkaman M, Afsharpaiman S H, Hoseini M J , Moradi M. Platelet
count and neonatal sepsis: a high prevalence of Enterobacter spp. Sing
Med J, 2009, 50(5): 482-485. [PubMed]
44. Tiago de Oliveira Boechat, Maria Fernanda Baylão Bueno
da Silveira, Wilian Faviere, Gerson Luiz de Macedo.Thrombocytopenia in
sepsis: an important prognosis factor; Revista Brasileira de Terapia
Intensiva; ISSN 0103-507XRev. bras. ter. intensiva vol.24 (1)Jan./Mar.
2012. [PubMed]
45. Charoo BA, Iqbal JI, Iqbal Q, Mushtaq S, Bhat AW, Nawaz I.
Nosocomial sepsis induced late onset thrombocytopenia in a neonatal
tertiary care unit:a prospective study. Hematol Oncol Stem Cell Ther
2009;(2):349-53. [PubMed]
46. Christensen RD, Henry E, Del Vecchio A. Thrombocytosis and
thrombocytopenia in the NICU: incidence, mechanisms and treatments. J
Matern Fetal Neonatal Med. 2012 Oct;25(4):15-7. [PubMed]
47. Murray NA, Howarth LJ, McCloy MP. Platelet transfusion in the
management of severe thrombocytopenia in neonatal intensive care unit
patients.Transfus Med 2002;(12):35–41. [PubMed]
48. Sainio S, Jarvenpaa A-S, Renlund M. Thrombocytopenia in term
infants: a population-based study. Obstet Gynecol
2000;(95):441–6. [PubMed]
49. de Moerloose P, Boehlen F, Extermann P. Neonatal thrombocytopenia:
incidence and characterization of maternal antiplatelet antibodies by
MAIPA assay. Br J Haematol 1998;(100):735–40.
50. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to
maternal thrombocytopenia. N Engl J Med 1993;329:1463–6. [PubMed]
51. Uhrynowska M, Niznikowska-Marks M, Zupanska B. Neonatal and
maternal thrombocytopenia: incidence and immune background. Eur J
Haematol 2000;(64):42–6. [PubMed]
52. Dreyfus M, Kaplan C, Verdy E. Frequency of immune thrombocytopenia
in newborns:a prospective study. Immune Thrombocytopenia Working Group.
Blood 1997;(89):4402–6. [PubMed]
How to cite this article?
Rabindran, Parakh H, Ramesh JK, Reddy P. Prevalence and course of
Thrombocytopenia in culture positive and culture negative Neonatal
Sepsis. Pediatr Rev: Int J Pediatr Res 2014;1(3):60-66. doi:
10.17511/ijpr.2014.3.001.